SiSaf Announces Positive Preclinical Data in its SiS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis

SiSaf Ltd, an RNA delivery and therapeutics company, is pleased to announce positive data confirming safety and efficacy of its Bio-Courier™ next generation silicon stabilized hybrid lipid nanoparticles (sshLNP) as an effective non-viral delivery system for Autosomal Dominant Osteopetrosis 2 (ADO2) siRNA ...

Related Keywords

Italy ,Laquila ,Abruzzo ,United States ,Texas ,American ,Anna Maria Teti ,Sisaf Bio ,Suzanne Saffie Siebert ,Antonio Maurizi ,Department Of Biotechnological ,Mineral Research ,Clinical Sciences ,Sisaf Ltd ,American Society Of Bone ,American Society ,Autosomal Dominant Osteopetrosis ,Professor Anna Maria Teti ,Applied Clinical Sciences ,Professor Teti ,